Vivos Therapeutics, Inc. (VVOS)
1.35
-0.06
(-4.26%)
USD |
NASDAQ |
Mar 03, 16:00
1.30
-0.05
(-3.70%)
After-Hours: 20:00
Vivos Therapeutics Cash from Investing (Quarterly) : 0.083M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 55.42M |
| Plus Therapeutics, Inc. | 1.297M |
| Atossa Therapeutics, Inc. | -0.007M |
| Abeona Therapeutics, Inc. | -64.63M |
| Cell Source, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.161M |
| Cash from Financing (Quarterly) | 2.763M |
| Free Cash Flow | -15.37M |
| Free Cash Flow Per Share (Quarterly) | -0.372 |
| Free Cash Flow to Equity (Quarterly) | -4.995M |
| Free Cash Flow to Firm (Quarterly) | -4.078M |
| Free Cash Flow Yield | -131.8% |